跳至主要内容
临床试验/NCT01432743
NCT01432743已完成2 期

Cartomerge Versus NavX Fusion in Catheter Ablation of Atrial Fibrillation

Barts & The London NHS Trust2 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2007年9月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
101
试验地点
2
主要终点
AF recurrence

研究概览

简要总结

Comparison of Two Strategies for Catheter Ablation of Atrial Fibrillation - a comparison of ablation guided by Cartomerge and NavX Fusion. 3D mapping systems are widely used in catheter ablation of AF. Integration of a previously acquired image of the left atrium into the electroanatomical (EA) map offers several potential advantages, including visualisation of the complex anatomy of the left atrium, reduction of fluoroscopy time and improved results . The two most widely used systems are Cartomerge (Biosense Webster, etc) and NavX Fusion (SJM, etc). Although both systems have been independently validated, their clinical utility has not previously been directly compared in a randomised trial

详细描述

Patients are randomised to either NavX Fusion or Cartomerge. They undergo a standard catheter ablation procedure and data is collected. Both systems are routinely used in our clinical practise. This is a comparison trial of 2 mapping technologies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Be at least 18 years of age
  • Be undergoing their first planned procedure for electrophysiology mapping and ablation in the left atrium of AF
  • Be willing and able to sign the study specific informed consent
  • Have a negative pregnancy test for female subjects of child bearing potential

排除标准

  • Have a left ventricular ejection fraction (LVEF) of <40% as evaluated by pre-procedure TTE
  • Have any contraindication or allergy to routine procedural medications or catheter materials
  • Have any condition for which the investigator feels it is unsafe for the subject to undergo an invasive electrophysiology procedure (EP) catheterisation
  • Be currently participating in another clinical research study
  • Have any condition for which the subject's life expectancy is less than twelve months

结局指标

主要结局

AF recurrence

时间窗: 6 months

Documentation of symptomatic arrhythmia or arrhythmia on a 7 day holter monitor at six-month follow-up

次要结局

  • Lesion distance from CT shell(At completion of catheter ablation procedure (distance at defined procedure endpoint) (between 0 - 6 hours after procedure start))
  • Procedural time points(At start, during and end of inpatient catheter ablation procedure. (between 0 & 6 hours after start of ablation procedure))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Richard Schilling

Professor of Cardiology and Cardiac Electrophysiology

Barts & The London NHS Trust

研究点 (2)

Loading locations...

相似试验